FindMyKOL
Clinical trialNCT03495817CompletedPhase 2Interventional

A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution

SponsorAclaris Therapeutics, Inc.Enrollment31Androgenetic Alopecia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Open label study to assess safety, tolerability, and efficacy of ATI-50002 in male and female subjects with androgenetic alopecia.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Aclaris Investigational Site

    Denver, Colorado, United States

  • Aclaris Investigational Site

    Portland, Oregon, United States

  • Aclaris Investigational Site

    Austin, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

ATI-50002
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Mar 2018
Primary completion
15 Oct 2019
Completion
30 Oct 2019
Last update posted
9 Dec 2020
Registered enrollment
31
Registry id
NCT03495817
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.